Skip To Main Content
Le contenu de ce site web est exclusivement réservé aux professionnels de santé en Belgique et au Luxembourg.
Campus Belgique
  • Aires thérapeutiques
  • Ressources
Campus Belgique
  • Aires thérapeutiques
  • Ressources
View Full Results

Éducation

Sort by

Filtres

Réinitialiser
  • Aires thérapeutiques

A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I

Roth Eli M et al. Atherosclerosis vol. 254 (2016): 254-262

Explorer

Introduction to hand and foot dermatitis

Explorer

Hot topics in atopic dermatitis: Hear it from the experts

Explorer

DERM 360°

Clinical challenges to achieve long-term disease control within treatment of moderate to severe AD.

Explorer

Why Don’t We Strike Early, Strike Strong?

Prof. Dr. Halvorsen, Prof. Dr. Sinnaeve & Prof. Dr. Martens

Explorer

COPD Research Forum

Explorer

Replay webinar « La vaccination contre la grippe chez les personnes âgées » - Prof. dr. Vandercam

Explorer

A Quick Guide to Nirsevimab SmPC (2024)

Explorer

Rhino Rounds International 2024 - Interview

Explorer

Slowly Expanded Lesions

A candidate biomarker for smoldering neuroinflammation in MS.

Explorer

Multiple sclerosis progression: time for a new mechanism-driven framework

Paper by Tanja Kuhlmann et al.

Explorer

Smouldering multiple sclerosis

Explorer